The coma in glaucoma: Retinal ganglion cell dysfunction and recovery

Area of Science:

• Ophthalmology and Neuroscience
• Retinal cell biology and disease mechanisms

Background:

• Glaucoma leads to irreversible vision loss primarily attributed to retinal ganglion cell (RGC) death.
• Current understanding suggests RGC degeneration is a terminal event, making vision loss permanent.

Purpose of the Study:

• To challenge the notion that RGC degeneration is irreversible.
• To explore the potential for visual function recovery in glaucoma patients through treatment.
• To investigate the underlying mechanisms of RGC dysfunction and recovery.

Main Methods:

• Summarized clinical evidence of vision improvement in glaucoma patients undergoing treatment.
• Conducted experimental studies to identify processes enabling functional recovery in RGCs.
• Investigated the conditions under which RGCs enter a state of dysfunction but remain recoverable.

Main Results:

• Accumulating clinical data indicates visual function can improve with treatment, especially in early glaucoma.
• Experimental findings demonstrate that RGCs can recover function after prolonged periods of dysfunction.
• The capacity for RGC recovery can be modulated, suggesting potential therapeutic targets.

Conclusions:

• Retinal ganglion cells may enter a reversible state of dysfunction ('comatose') before cell death.
• Relieving RGC stress can facilitate functional recovery, challenging the paradigm of irreversible vision loss.
• Detecting RGC dysfunction and promoting recovery offers significant clinical potential for early glaucoma detection and vision restoration.